Post Marketing Surveillance of Radiotherapy With Concomitant and Adjuvant Chemotherapy With Temozolomide for Patients With Newly Diagnosed and Operated Glioblastoma Multiforme
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2014
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2008 Trial phase changed from IV to none as reported by ClinicalTrials.gov.
- 21 Jul 2008 New trial record.